2023
Expert consensus‐based guidance on approaches to opioid management in individuals with advanced cancer‐related pain and nonmedical stimulant use
Jones K, Khodyakov D, Han B, Arnold R, Dao E, Morrison J, Kapo J, Meier D, Paice J, Liebschutz J, Ritchie C, Merlin J, Bulls H. Expert consensus‐based guidance on approaches to opioid management in individuals with advanced cancer‐related pain and nonmedical stimulant use. Cancer 2023, 129: 3978-3986. PMID: 37691479, PMCID: PMC10910244, DOI: 10.1002/cncr.34921.Peer-Reviewed Original ResearchConceptsCancer-related painConsensus-based guidanceStimulant useUncertain appropriatenessOpioid taperingLonger prognosisShort prognosisPalliative careAddiction expertsNonmedical stimulant useRAND/UCLAStimulant use disorderHarm reduction measuresAdvanced cancerPatient prognosisClinical appropriatenessPainUse disordersPrognosisPatientsExpert consensusOpioidsCancerDelphi panelClinicians
2022
Expert Consensus-Based Guidance on Approaches to Opioid Management in Individuals with Advanced Cancer-Related Pain and Opioid Misuse or Use Disorder: Results of a Delphi Study (RP305)
Jones K, Merlin J, Arnold R, Meier D, Kapo J, Paice J. Expert Consensus-Based Guidance on Approaches to Opioid Management in Individuals with Advanced Cancer-Related Pain and Opioid Misuse or Use Disorder: Results of a Delphi Study (RP305). Journal Of Pain And Symptom Management 2022, 63: 1070. DOI: 10.1016/j.jpainsymman.2022.04.021.Peer-Reviewed Original ResearchOpioid use disorderBuprenorphine/naloxoneCancer-related painUrine drug testsOpioid misuseUncertain appropriatenessOpioid managementLonger prognosisComorbid painShort prognosisTraditional opioidsUse disordersUntreated opioid use disorderFull opioid agonistsPrescription of methadoneCancer pain managementDrug testsExpert panel consensusHigh-risk behaviorsMethadone accessTaper opioidsPrescribed opioidsUncontrolled painOUD treatmentPain management